Top 10 Companies in the (S)-3-Hydroxytetrahydrofuran (CAS 86087-23-2) Market (2026): Market Leaders Powering Global Pharmaceutical Synthesis

MARKET INSIGHTS

Global (S)-3-Hydroxytetrahydrofuran (CAS 86087-23-2) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 6.5% during the forecast period.

(S)-3-Hydroxytetrahydrofuran is a chiral building block and fine chemical intermediate characterized by a tetrahydrofuran ring bearing a hydroxyl group at the 3-position in the (S)-enantiomeric configuration. This compound plays a vital role in asymmetric synthesis and is widely utilized in the pharmaceutical industry as a key precursor for the synthesis of antiviral agents, protease inhibitors, and other bioactive molecules. Its high enantiomeric purity and reactive hydroxyl functionality make it particularly valuable in the production of complex drug molecules where stereochemical precision is critical.

The market is witnessing steady growth driven by rising demand for enantiomerically pure intermediates in pharmaceutical manufacturing, expanding applications in agrochemical synthesis, and growing investment in chiral chemistry research. Furthermore, the increasing prevalence of chronic and infectious diseases has accelerated drug development pipelines globally, directly boosting consumption of specialized chiral building blocks such as (S)-3-Hydroxytetrahydrofuran. Key suppliers operating in this space include TCI Chemicals, Sigma-Aldrich (Merck KGaA), Alfa Aesar, and various fine chemical manufacturers across Asia-Pacific and Europe.

(S)-3-Hydroxytetrahydrofuran (CAS 86087-23-2) Market – View in Detailed Research Report

Top 10 Companies in the (S)-3-Hydroxytetrahydrofuran (CAS 86087-23-2) Market (2026)

10️⃣ 1. Thermo Fisher Scientific (Alfa Aesar)

Headquarters: Waltham, Massachusetts, USA
Key Offering: Pharmaceutical Grade (S)-3-Hydroxytetrahydrofuran, custom synthesis services

Thermo Fisher Scientific, through its Alfa Aesar brand, offers a comprehensive catalog of enantiomerically pure chemicals, including (S)-3-Hydroxytetrahydrofuran, catering to pharmaceutical, biotechnology, and research institutions worldwide. The company leverages its vertically integrated supply chain and stringent quality control systems to deliver high-purity materials that meet regulatory requirements such as ICH Q7 and Q8.

Sustainability and Growth Initiatives:

• Investment in green chemistry protocols to reduce solvent usage.
• Expansion of contract manufacturing services for chiral intermediates.
• Partnerships with academic institutions to develop new asymmetric catalysts.

9️⃣ 2. TCI Chemicals

Headquarters: Tokyo, Japan
Key Offering: High-purity (S)-3-Hydroxytetrahydrofuran, analytical services

TCI Chemicals provides a broad range of fine chemicals with a focus on enantiomerically pure intermediates. Their robust R&D pipeline supports the development of novel synthesis routes and they maintain a strong presence in the Asian market.

Sustainability and Growth Initiatives:

• Implementation of energy-efficient manufacturing processes.
• Development of biocatalytic synthesis platforms.
• Collaboration with pharmaceutical firms for early-stage development.

8️⃣ 3. Sigma-Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany
Key Offering: Pharmaceutical Grade (S)-3-Hydroxytetrahydrofuran, chiral auxiliary kits

Sigma-Aldrich offers high-quality chiral building blocks and supports researchers with comprehensive analytical data. Their global distribution network ensures timely delivery to key markets.

Sustainability and Growth Initiatives:

• Adoption of sustainable raw material sourcing.
• Investment in process intensification technologies.
• Support for green chemistry initiatives in academia.

7️⃣ 4. COMBI-BLOCKS

Headquarters: Charlotte, North Carolina, USA
Key Offering: Custom chiral synthesis, (S)-3-Hydroxytetrahydrofuran

COMBI-BLOCKS specializes in custom synthesis of chiral intermediates for pharmaceutical companies, offering rapid turnaround and high enantiomeric excess.

Sustainability and Growth Initiatives:

• Continuous improvement of solvent recovery systems.
• Development of modular flow chemistry setups.
• Engagement with CDMOs to streamline supply chains.

6️⃣ 5. Shaanxi Dideu Medichem Co., Ltd.

Headquarters: Xi’an, China
Key Offering: Bulk (S)-3-Hydroxytetrahydrofuran, cost-effective production

Shaanxi Dideu Medichem focuses on large-scale production of chiral intermediates, providing competitive pricing for generic pharmaceutical manufacturers.

Sustainability and Growth Initiatives:

• Implementation of waste minimization protocols.
• Investment in renewable energy sources for manufacturing.
• Collaboration with local universities for catalyst development.

5️⃣ 6. Hairui Chemical

Headquarters: Chengdu, China
Key Offering: Pharmaceutical Grade (S)-3-Hydroxytetrahydrofuran, custom synthesis

Hairui Chemical offers high-purity chiral intermediates with a focus on meeting strict regulatory standards for pharmaceutical applications.

Sustainability and Growth Initiatives:

• Adoption of green chemistry principles in synthesis.
• Development of enzyme-catalyzed resolution processes.
• Expansion of distribution channels in Asia-Pacific.

4️⃣ 7. Nanjing Chemlin Chemical Industry Co., Ltd.

Headquarters: Nanjing, China
Key Offering: Bulk (S)-3-Hydroxytetrahydrofuran, cost-effective supply

Nanjing Chemlin focuses on providing high-quality chiral intermediates to both domestic and export markets, with an emphasis on scalable production.

Sustainability and Growth Initiatives:

• Implementation of energy-efficient manufacturing.
• Investment in biocatalytic technologies.
• Partnerships with pharmaceutical companies for early-stage development.

3️⃣ 8. Fluorochem Ltd.

Headquarters: Birmingham, United Kingdom
Key Offering: Pharmaceutical Grade (S)-3-Hydroxytetrahydrofuran, analytical support

Fluorochem supplies high-purity chiral intermediates and provides comprehensive analytical data to support regulatory submissions.

Sustainability and Growth Initiatives:

• Use of renewable solvents in synthesis.
• Development of continuous flow processes.
• Collaboration with research institutions for catalyst development.

2️⃣ 9. Zhengzhou Alfa Chemical Co., Ltd.

Headquarters: Zhengzhou, China
Key Offering: Bulk (S)-3-Hydroxytetrahydrofuran, cost-effective supply

Zhengzhou Alfa Chemical focuses on large-scale production and distribution of chiral intermediates to the Asian market.

Sustainability and Growth Initiatives:

• Implementation of waste minimization strategies.
• Investment in renewable energy for production facilities.
• Partnerships with local universities for catalyst research.

1️⃣ 10. China National Chemical Corporation (CNNC)

Headquarters: Beijing, China
Key Offering: Pharmaceutical Grade (S)-3-Hydroxytetrahydrofuran, integrated supply chain services

CNNC provides a broad portfolio of fine chemicals and supports pharmaceutical companies with end-to-end supply chain solutions.

Sustainability and Growth Initiatives:

• Adoption of green chemistry practices across manufacturing units.
• Development of biocatalytic synthesis platforms.
• Expansion of global distribution networks.

Download FREE Sample Report: (S)-3-Hydroxytetrahydrofuran (CAS 86087-23-2) Market – View in Detailed Research Report

---

Get Full Report: (S)-3-Hydroxytetrahydrofuran (CAS 86087-23-2) Market – View in Detailed Research Report

Outlook

The forecast period from 2026 to 2034 is expected to see a steady increase in demand for (S)-3-Hydroxytetrahydrofuran, driven by the expansion of antiviral and CNS drug pipelines, growth in contract manufacturing, and advancements in biocatalytic synthesis. The market will continue to be shaped by regulatory emphasis on enantiomeric purity and the need for scalable, cost‑effective production technologies.

Future Trends

Key emerging trends include the adoption of continuous flow chemistry and immobilized enzyme biocatalysis, increased outsourcing of chiral intermediate synthesis to specialized suppliers, and a focus on green chemistry to lower environmental impact. These developments are expected to improve economics, enhance product quality, and expand the application space of (S)-3-Hydroxytetrahydrofuran beyond traditional pharmaceutical uses.